| 1070 |
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
|
2026-08-31 |
154 |
| 1069 |
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
|
2026-08-31 |
148 |
| 1068 |
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
|
2026-08-31 |
134 |
| 1067 |
ATLAS, Lancet 2026
|
2026-07-30 |
271 |
| 1066 |
TRACE-5 BAO, Lancet 2026
|
2026-07-30 |
262 |
| 1065 |
ORIENTAL MEVO Trial, NEJM 2026
|
2026-07-30 |
264 |
| 1064 |
CHAMPION-AF와 CLOSURE-A:우리는 누구에게 LAAC를 해야 하는가?
|
2026-06-30 |
356 |
| 1063 |
Left Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
|
2026-06-30 |
378 |
| 1062 |
Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation
|
2026-06-30 |
327 |
| 1061 |
Increased Risk of Ischemic Events in Patients With Stroke Treated With Clopidogrel and a P-CAB or PPI
|
2026-05-28 |
1,113 |
| 1060 |
Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke—ACTISAVE
|
2026-05-28 |
455 |
| 1059 |
Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation The STABLED Randomized Clinical Trial
|
2026-05-28 |
420 |
| 1058 |
Asundexian for Secondary Stroke Prevention (OCEANIC-STROKE trial)
|
2026-04-29 |
720 |
| 1057 |
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage (TRIDENT trial)
|
2026-04-29 |
510 |
| 1056 |
Rescue Versus First-Line Intracranial Stenting During Thrombectomy for Acute Ischemic Stroke: A Propensity-Weighted Analysis of the RESISTANT Registry
|
2026-04-29 |
570 |
HOME
LOGIN
